MARKET

OMCL

OMCL

Omnicell
NASDAQ

Real-time Quotes | Nasdaq Last Sale

158.27
+3.57
+2.31%
Opening 14:43 09/22 EDT
OPEN
154.78
PREV CLOSE
154.70
HIGH
158.56
LOW
153.90
VOLUME
80.74K
TURNOVER
--
52 WEEK HIGH
162.86
52 WEEK LOW
67.66
MARKET CAP
6.88B
P/E (TTM)
120.65
1D
5D
1M
3M
1Y
5Y
FDS Amplicare and HealthPlanOne Announce Inaugural Pathway to Medicare Award Winners
/PRNewswire/ -- , which builds industry-leading SaaS technology solutions that strengthen the health of retail pharmacies and their patients, and , a leading provider of Medicare enrollment solutions staffed by licensed Medicare advisors who provide except...
PR Newswire - PRF · 2d ago
Syneos Health's (SYNH) New Buyout Boosts Clinical Solutions Arm
Zacks.com · 6d ago
Top Robotics Stocks for Q4 2021
The number of robotics and automation companies has increased dramatically in recent decades as corporations seek to produce goods and services more efficiently, often replacing more expensive human employees in the process. Examples of companies that off...
Investopedia · 09/15 17:25
Omnicell (OMCL) New Buyout Expands Patient Engagement Suite
Zacks.com · 09/13 14:33
Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?
Zacks.com · 09/13 10:20
Is Omnicell (OMCL) a Solid Growth Stock? 3 Reasons to Think " Yes "
Zacks.com · 09/09 16:45
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
Zacks.com · 09/09 10:20
3 MedTech Sectors Benefiting Despite COVID-19 Resurgence
Zacks.com · 09/08 14:47
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OMCL. Analyze the recent business situations of Omnicell through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OMCL stock price target is 167.50 with a high estimate of 188.00 and a low estimate of 135.00.
EPS
Institutional Holdings
Institutions: 500
Institutional Holdings: 49.16M
% Owned: 113.08%
Shares Outstanding: 43.47M
TypeInstitutionsShares
Increased
126
2.30M
New
36
555.56K
Decreased
143
1.51M
Sold Out
39
349.73K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.04%
Healthcare Equipment & Supplies
+1.02%
Key Executives
Chairman/Director/President/Chief Executive Officer
Randall Lipps
Chief Financial Officer/Executive Vice President
Peter Kuipers
Chief Human Resource Officer/Executive Vice President
Christine Mellon
Executive Vice President/Chief Administrative Officer
Daniel Johnston
Executive Vice President
Scott Seidelmann
Lead Director/Independent Director
James Judson
Director
Robin Seim
Independent Director
Joanne Bauer
Independent Director
Edward Bousa
Independent Director
Vance Moore
Independent Director
Mark Parrish
Independent Director
Bruce Scott
Independent Director
Bruce Smith
Independent Director
Sara White
No Data
About OMCL
Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.

Webull offers kinds of Omnicell, Inc. stock information, including NASDAQ:OMCL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OMCL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OMCL stock methods without spending real money on the virtual paper trading platform.